Avita Medical | 1811094D - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Accuray USD 199.44M 4.83M 2025-12
Celltrion KRW 288.01B 4.7B 2026-06
Clinuvel Pharmaceuticals AUD 17.85M 9.36M 2025-12
Cochlear AUD 558.9M 43.4M 2025-12
CSL USD 4.61B 207M 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Kangmei Pharma CNY 5.1B 280.48M 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Mayne Pharma AUD 313.94M 18.28M 2024-06
Medical Developments International AUD 5.56M 2.26M 2025-12
Nanosonics AUD 36.59M 3.2M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 107.28M 18.54M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pacific Edge NZD 6.82M 400K 2026-06
Pharma Mar EUR 125.39M 26.97M 2026-09
Polynovo AUD 22.81M 5.07M 2025-12
PYC Therapeutics AUD 11.01M 1.31M 2025-12
Qiagen NV USD 581.45M 102.34M 2026-06
Ramsay Health Care AUD 3.95B 514.2M 2025-12
ResMed USD 1.4B 43.9M 2026-06
Sartorius EUR 1.55B 102.8M 2026-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Telix Pharmaceuticals AUD 242.34M 10.72M 2026-06
Tilray USD 259.32M 8.32M 2025-09
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.74B 277.02M 2026-09